Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
April-2018 Volume 17 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
April-2018 Volume 17 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

The polyaromatic hydrocarbon β-naphthoflavone alters binding of YY1, Sp1, and Sp3 transcription factors to the Dp71 promoter in hepatic cells

  • Authors:
    • Carolina Becerril‑Esquivel
    • Katia Peñuelas‑Urquides
    • Erik Blancas‑Sánchez
    • Pablo Zapata‑Benavides
    • Beatriz Silva‑Ramírez
    • Arturo Chávez‑Reyes
    • Fabiola Castorena‑Torres
    • Bulmaro Cisneros
    • Mario Bermúdez de León
  • View Affiliations / Copyright

    Affiliations: Departamento de Biología Molecular, Centro de Investigación Biomédica del Noreste, Instituto Mexicano del Seguro Social, Monterrey, Nuevo León 64720, México, Universidad Autónoma de Nuevo León, UANL, Facultad de Ciencias Biológicas, San Nicolás de los Garza, Nuevo León 66451, México, Departamento de Inmunogenética, Centro de Investigación Biomédica del Noreste, Instituto Mexicano del Seguro Social, Monterrey, Nuevo León 64720, México, Centro de Investigación y de Estudios Avanzados del IPN Unidad Monterrey, Apodaca, Nuevo León 66600, México, Escuela de Medicina, Tecnológico de Monterrey, Monterrey, Nuevo León 64710, México, Departamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados del IPN unidad Zacatenco, Ciudad de México 07360, México
  • Pages: 6150-6155
    |
    Published online on: February 21, 2018
       https://doi.org/10.3892/mmr.2018.8626
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The smallest product of the Duchenne muscular dystrophy gene, dystrophin (Dp)71, is ubiquitously expressed in nonmuscle tissues. We previously showed that Dp71 expression in hepatic cells is modulated in part by stimulating factor 1 (Sp1), stimulating protein 3 (Sp3), and yin yang 1 (YY1) transcription factors, and that the polyaromatic hydrocarbon, β-naphthoflavone (β‑NF), downregulates Dp71 expression. The aim of the present study was to determine whether β‑NF represses Dp71 expression by altering mRNA stability or its promoter activity. Reverse transcription‑quantitative polymerase chain reaction was used to measure half‑life mRNA levels in β‑NF‑treated cells exposed to actinomycin D, an inhibitor of transcription, for 0, 4, 8, 12 and 16 h. Transient transfections with a plasmid carrying the Dp71 basal promoter fused to luciferase reporter gene were carried out in control and β‑NF‑treated cells. Electrophoretic mobility shift assays (EMSAs) were performed with labeled probes, corresponding to Dp71 promoter sequences, and nuclear extracts of control and β‑NF‑treated cells. To the best of our knowledge, the results demonstrated for the first time that this negative regulation takes place at the promoter level rather than the mRNA stability level. Interestingly, using EMSAs, β‑NF reduced binding of YY1, Sp1, and Sp3 to the Dp71 promoter. It also suggests that β‑NF may modulate the expression of other genes regulated by these transcription factors. In conclusion, β‑NF represses Dp71 expression in hepatic cells by altering binding of YY1, Sp1, and Sp3 to the Dp71 promoter.
View Figures

Figure 1

Figure 2

Figure 3

View References

1 

Ahn AH and Kunkel LM: The structural and functional diversity of dystrophin. Nat Genet. 3:283–291. 1993. View Article : Google Scholar : PubMed/NCBI

2 

Koenig M, Monaco AP and Kunkel LM: The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell. 53:219–228. 1988. View Article : Google Scholar : PubMed/NCBI

3 

Bar S, Barnea E, Levy Z, Neuman S, Yaffe D and Nudel U: A novel product of the Duchenne muscular dystrophy gene which greatly differs from the known isoforms in its structure and tissue distribution. Biochem J. 272:557–560. 1990. View Article : Google Scholar : PubMed/NCBI

4 

Byers TJ, Lidov HG and Kunkel LM: An alternative dystrophin transcript specific to peripheral nerve. Nat Genet. 4:77–81. 1993. View Article : Google Scholar : PubMed/NCBI

5 

D'Souza VN, Nguyen TM, Morris GE, Karges W, Pillers DA and Ray PN: A novel dystrophin isoform is required for normal retinal electrophysiology. Hum Mol Genet. 4:837–842. 1995. View Article : Google Scholar : PubMed/NCBI

6 

Lidov HG, Selig S and Kunkel LM: Dp140: A novel 140 kDa CNS transcript from the dystrophin locus. Hum Mol Genet. 4:329–335. 1995. View Article : Google Scholar : PubMed/NCBI

7 

Greenberg DS, Schatz Y, Levy Z, Pizzo P, Yaffe D and Nudel U: Reduced levels of dystrophin associated proteins in the brains of mice deficient for Dp71. Hum Mol Genet. 5:1299–1303. 1996. View Article : Google Scholar : PubMed/NCBI

8 

Hugnot JP, Gilgenkrantz H, Vincent N, Chafey P, Morris GE, Monaco AP, Berwald-Netter Y, Koulakoff A, Kaplan JC, Kahn A, et al: Distal transcript of the dystrophin gene initiated from an alternative first exon and encoding a 75-kDa protein widely distributed in nonmuscle tissues. Proc Natl Acad Sci USA. 89:pp. 7506–7510. 1992; View Article : Google Scholar : PubMed/NCBI

9 

Greenberg DS, Sunada Y, Campbell KP, Yaffe D and Nudel U: Exogenous Dp71 restores the levels of dystrophin associated proteins but does not alleviate muscle damage in mdx mice. Nat Genet. 8:340–344. 1994. View Article : Google Scholar : PubMed/NCBI

10 

Cox GA, Sunada Y, Campbell KP and Chamberlain JS: Dp71 can restore the dystrophin-associated glycoprotein complex in muscle but fails to prevent dystrophy. Nat Genet. 8:333–339. 1994. View Article : Google Scholar : PubMed/NCBI

11 

Sarig R, Mezger-Lallemand V, Gitelman I, Davis C, Fuchs O, Yaffe D and Nudel U: Targeted inactivation of Dp71, the major non-muscle product of the DMD gene: Differential activity of the Dp71 promoter during development. Hum Mol Genet. 8:1–10. 1999. View Article : Google Scholar : PubMed/NCBI

12 

Lambert M, Chafey P, Hugnot JP, Koulakoff A, Berwald-Netter Y, Billard C, Morris GE, Kahn A, Kaplan JC and Gilgenkrantz H: Expression of the transcripts initiated in the 62nd intron of the dystrophin gene. Neuromuscul Disord. 3:519–524. 1993. View Article : Google Scholar : PubMed/NCBI

13 

Acosta R, Montanez C, Fuentes-Mera L, Gonzalez E, Gómez P, Quintero-Mora L, Mornet D, Alvarez-Salas LM and Cisneros B: Dystrophin Dp71 is required for neurite outgrowth in PC12 cells. Exp Cell Res. 296:265–275. 2004. View Article : Google Scholar : PubMed/NCBI

14 

Enríquez-Aragón JA, Cerna-Cortès J, Bermúdez de León M, García-Sierra F, González E, Mornet D and Cisneros B: Dystrophin Dp71 in PC12 cell adhesion. Neuroreport. 16:235–238. 2005. View Article : Google Scholar : PubMed/NCBI

15 

Tadayoni R, Rendon A, Soria-Jasso LE and Cisneros B: Dystrophin Dp71: the smallest but multifunctional product of the Duchenne muscular dystrophy gene. Mol Neurobiol. 45:43–60. 2012. View Article : Google Scholar : PubMed/NCBI

16 

Villarreal-Silva M, Centeno-Cruz F, Suàrez-Sànchez R, Garrido E and Cisneros B: Knockdown of dystrophin Dp71 impairs PC12 cells cycle: Localization in the spindle and cytokinesis structures implies a role for Dp71 in cell division. PLoS One. 6:e235042011. View Article : Google Scholar : PubMed/NCBI

17 

de León MB, Montañez C, Gómez P, Morales-Lázaro SL, Tapia-Ramírez V, Valadez-Graham V, Recillas-Targa F, Yaffe D, Nudel U and Cisneros B: Dystrophin Dp71 expression is down-regulated during myogenesis: Role of Sp1 and Sp3 on the Dp71 promoter activity. J Biol Chem. 280:5290–5299. 2005. View Article : Google Scholar : PubMed/NCBI

18 

Peñuelas-Urquides K, Becerril-Esquivel C, Mendoza-de-León LC, Silva-Ramírez B, Dávila-Velderrain J, Cisneros B and de León MB: Transcription factors YY1, Sp1 and Sp3 modulate dystrophin Dp71 gene expression in hepatic cells. Biochem J. 473:1967–1976. 2016. View Article : Google Scholar : PubMed/NCBI

19 

Morales-Làzaro SL, Gonzàlez-Ramirez R, Gòmez P, Tapia-Ramirez V, de León MB and Cisneros B: Induction of dystrophin Dp71 expression during neuronal differentiation: Opposite roles of Sp1 and AP2alpha in Dp71 promoter activity. J Neurochem. 112:474–485. 2010. View Article : Google Scholar : PubMed/NCBI

20 

Gerets HH, Tilmant K, Gerin B, Chanteux H, Depelchin BO, Dhalluin S and Atienzar FA: Characterization of primary human hepatocytes, HepG2 cells and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins. Cell Biol Toxicol. 28:69–87. 2012. View Article : Google Scholar : PubMed/NCBI

21 

Volkov MS, Bolotina NA, Evteev VA and Koblyakov VA: Ah-receptor-independent stimulation of hepatoma 27 culture cell proliferation by polycyclic aromatic hydrocarbons. Biochemistry. 77:201–207. 2012.PubMed/NCBI

22 

Bermúdez de Leòn M, Gómez P, Elizondo G, Zatarain-Palacios R, García-Sierra F and Cisneros B: Beta-naphthoflavone represses dystrophin Dp71 expression in hepatic cells. Biochim Biophys Acta. 1759:152–158. 2006. View Article : Google Scholar : PubMed/NCBI

23 

López-Terrada D, Cheung SW, Finegold MJ and Knowles BB: Hep G2 is a hepatoblastoma-derived cell line. Hum Pathol. 40:1512–1515. 2009. View Article : Google Scholar

24 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

25 

Schreiber E, Matthias P, Müller MM and Schaffner W: Rapid detection of octamer binding proteins with ‘mini-extracts’, prepared from a small number of cells. Nucleic Acids Res. 17:64191989. View Article : Google Scholar : PubMed/NCBI

26 

Tennyson CN, Dally GY, Ray PN and Worton RG: Expression of the dystrophin isoform Dp71 in differentiating human fetal myogenic cultures. Hum Mol Genet. 5:1559–1566. 1996. View Article : Google Scholar : PubMed/NCBI

27 

Jokela TA, Makkonen KM, Oikari S, Kärnä R, Koli E, Hart GW, Tammi RH, Carlberg C and Tammi MI: Cellular content of UDP-N-acetylhexosamines controls hyaluronan synthase 2 expression and correlates with O-linked N-acetylglucosamine modification of transcription factors YY1 and SP1. J Biol Chem. 286:33632–33640. 2011. View Article : Google Scholar : PubMed/NCBI

28 

Tan NY and Khachigian LM: Sp1 phosphorylation and its regulation of gene transcription. Mol Cell Biol. 29:2483–2488. 2009. View Article : Google Scholar : PubMed/NCBI

29 

Chiba T, Chihara J and Furue M: Role of the arylhydrocarbon receptor (AhR) in the pathology of asthma and COPD. J Allergy. 2012:3723842012. View Article : Google Scholar

30 

Nebert DW, Roe AL, Dieter MZ, Solis WA, Yang Y and Dalton TP: Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochem Pharmacol. 59:65–85. 2000. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Becerril‑Esquivel C, Peñuelas‑Urquides K, Blancas‑Sánchez E, Zapata‑Benavides P, Silva‑Ramírez B, Chávez‑Reyes A, Castorena‑Torres F, Cisneros B and Bermúdez de León M: The polyaromatic hydrocarbon β-naphthoflavone alters binding of YY1, Sp1, and Sp3 transcription factors to the Dp71 promoter in hepatic cells. Mol Med Rep 17: 6150-6155, 2018.
APA
Becerril‑Esquivel, C., Peñuelas‑Urquides, K., Blancas‑Sánchez, E., Zapata‑Benavides, P., Silva‑Ramírez, B., Chávez‑Reyes, A. ... Bermúdez de León, M. (2018). The polyaromatic hydrocarbon β-naphthoflavone alters binding of YY1, Sp1, and Sp3 transcription factors to the Dp71 promoter in hepatic cells. Molecular Medicine Reports, 17, 6150-6155. https://doi.org/10.3892/mmr.2018.8626
MLA
Becerril‑Esquivel, C., Peñuelas‑Urquides, K., Blancas‑Sánchez, E., Zapata‑Benavides, P., Silva‑Ramírez, B., Chávez‑Reyes, A., Castorena‑Torres, F., Cisneros, B., Bermúdez de León, M."The polyaromatic hydrocarbon β-naphthoflavone alters binding of YY1, Sp1, and Sp3 transcription factors to the Dp71 promoter in hepatic cells". Molecular Medicine Reports 17.4 (2018): 6150-6155.
Chicago
Becerril‑Esquivel, C., Peñuelas‑Urquides, K., Blancas‑Sánchez, E., Zapata‑Benavides, P., Silva‑Ramírez, B., Chávez‑Reyes, A., Castorena‑Torres, F., Cisneros, B., Bermúdez de León, M."The polyaromatic hydrocarbon β-naphthoflavone alters binding of YY1, Sp1, and Sp3 transcription factors to the Dp71 promoter in hepatic cells". Molecular Medicine Reports 17, no. 4 (2018): 6150-6155. https://doi.org/10.3892/mmr.2018.8626
Copy and paste a formatted citation
x
Spandidos Publications style
Becerril‑Esquivel C, Peñuelas‑Urquides K, Blancas‑Sánchez E, Zapata‑Benavides P, Silva‑Ramírez B, Chávez‑Reyes A, Castorena‑Torres F, Cisneros B and Bermúdez de León M: The polyaromatic hydrocarbon β-naphthoflavone alters binding of YY1, Sp1, and Sp3 transcription factors to the Dp71 promoter in hepatic cells. Mol Med Rep 17: 6150-6155, 2018.
APA
Becerril‑Esquivel, C., Peñuelas‑Urquides, K., Blancas‑Sánchez, E., Zapata‑Benavides, P., Silva‑Ramírez, B., Chávez‑Reyes, A. ... Bermúdez de León, M. (2018). The polyaromatic hydrocarbon β-naphthoflavone alters binding of YY1, Sp1, and Sp3 transcription factors to the Dp71 promoter in hepatic cells. Molecular Medicine Reports, 17, 6150-6155. https://doi.org/10.3892/mmr.2018.8626
MLA
Becerril‑Esquivel, C., Peñuelas‑Urquides, K., Blancas‑Sánchez, E., Zapata‑Benavides, P., Silva‑Ramírez, B., Chávez‑Reyes, A., Castorena‑Torres, F., Cisneros, B., Bermúdez de León, M."The polyaromatic hydrocarbon β-naphthoflavone alters binding of YY1, Sp1, and Sp3 transcription factors to the Dp71 promoter in hepatic cells". Molecular Medicine Reports 17.4 (2018): 6150-6155.
Chicago
Becerril‑Esquivel, C., Peñuelas‑Urquides, K., Blancas‑Sánchez, E., Zapata‑Benavides, P., Silva‑Ramírez, B., Chávez‑Reyes, A., Castorena‑Torres, F., Cisneros, B., Bermúdez de León, M."The polyaromatic hydrocarbon β-naphthoflavone alters binding of YY1, Sp1, and Sp3 transcription factors to the Dp71 promoter in hepatic cells". Molecular Medicine Reports 17, no. 4 (2018): 6150-6155. https://doi.org/10.3892/mmr.2018.8626
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team